Columbus Life Sciences Fund IV has been recently incorporated and accepted by the CNMV. CVP's fund IV will have a size of EUR 150 million and will follow the same strategy as the previous funds. 10 - 12 investments in opportunities in all stages of (bio)pharmaceutical drug development and advanced biopharmaceutical manufacturing technologies in incorporated companies and companies founded by the fund team and with a short investment period.

About Columbus Venture Partners:

Columbus Venture Partners was founded in 2016 by Javier García and Damià Tormo and has a fund portfolio of over €250 million under management, following a strategy of building companies from scratch with a focus on investing in opportunities at all stages of (bio)pharmaceutical drug development and advanced biopharmaceutical manufacturing technologies.

The first two funds launched by Columbus in 2016 of €41 million and in 2019 of €74 million are at a very advanced stage of divestment following an impressive track record of successful divestment results among others: Viralgen Vector Core, Viralgen Commercial, and Askbio (all acquired by Bayer), PTS/Curapath(acquired by Arcline), TAAV (acquired by Askbio), Aura (IPO on Nasdaq), Sanifit (acquired by Vifor Pharma), Recovid (acquired by Vitro) or Algenex (acquired by Insud Pharma).

While the third fund, which has completed its investment period, was launched in 2021 with 120 million euros and has invested in companies such as Minoryx (in Barcelona), Nerre (in UK), Aleta (in Boston) or Syngoi and Cocoon (both in Bilbao).

Columbus has different offices in Spain (Madrid, Valencia, Barcelona and San Sebastian) and in Boston. Columbus' professional team has 24 employees and combines solid scientific, medical and business knowledge with extensive experience in the field of corporate biotechnology.

Fuente: Columbus Venture Partners

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Eleventh acquisition under Meridia's JV ...

by Meridia Capital Partners

This acquisition signifies Meridia's entry into one of the most esteem...

Photos Stream